CD19 and chronic myelogenous leukemia, BCR-ABL1 positive: The CD19+ Burkitt’s lymphoma cell line Raji, CD19+ acute lymphoblastic leukemia cell line Nalm6, and CD19− chronic myelogenous leukemia cell line K562 were incubated with loaded anti-CD19-CAR-EVs or unmodified EVs.